Original Research
Published on 22 Jul 2022
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.942341
- 4,204 views
- 12 citations
Type at least 3 characters
1,009 articles
Articles
Original Research
Published on 22 Jul 2022
A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.914032
- 3,516 views
- 15 citations
Original Research
Published on 22 Jul 2022
Stemness Analysis Uncovers That The Peroxisome Proliferator-Activated Receptor Signaling Pathway Can Mediate Fatty Acid Homeostasis In Sorafenib-Resistant Hepatocellular Carcinoma Cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.912694
- 3,936 views
- 7 citations
Original Research
Published on 15 Jul 2022
Effects of glycolysis and polyamine predation on intestinal epithelial barrier in colorectal cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.961257
- 2,066 views
- 3 citations
Review
Published on 15 Jul 2022
Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.953668
- 2,763 views
- 9 citations
Original Research
Published on 14 Jul 2022
Glaucocalyxin A Inhibits the Malignant Progression of Epithelial Ovarian Cancer by Affecting the MicroRNA-374b-5p/HMGB3/Wnt-β-Catenin Pathway Axis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.955830
- 1,840 views
- 2 citations
Mini Review
Published on 14 Jul 2022
Current Progress in Cancer Treatment Using Nanomaterials
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.930125
- 12,556 views
- 41 citations
Original Research
Published on 14 Jul 2022
SETD3 Methyltransferase Regulates PLK1 Expression to Promote In Situ Hepatic Carcinogenesis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.882202
- 3,708 views
- 4 citations
Systematic Review
Published on 13 Jul 2022
Capsaicin: A Two-Decade Systematic Review of Global Research Output and Recent Advances Against Human Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.908487
- 15,606 views
- 31 citations
Original Research
Published on 13 Jul 2022
Stable CDK12 Knock-Out Ovarian Cancer Cells Do Not Show Increased Sensitivity to Cisplatin and PARP Inhibitor Treatment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.903536
- 4,754 views
- 3 citations
Original Research
Published on 13 Jul 2022
Flavokawain A Reduces Tumor-Initiating Properties and Stemness of Prostate Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.943846
- 4,782 views
- 7 citations
Original Research
Published on 13 Jul 2022
Endoscopic or Follow-up Treatment for Gastric Indeterminate Tumors Is the Preferred Method of Management
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.947810
- 1,307 views
Original Research
Published on 12 Jul 2022
The Combination of AFP and “Up-To-Seven” Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.959151
- 3,978 views
- 2 citations
Original Research
Published on 12 Jul 2022
DHW-208, A Novel Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Has Anti-Hepatocellular Carcinoma Activity Through Promoting Apoptosis and Inhibiting Angiogenesis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.955729
- 1,970 views
- 4 citations
Review
Published on 12 Jul 2022
Chemopreventive Potential of Dietary Nanonutraceuticals for Prostate Cancer: An Extensive Review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.925379
- 5,120 views
- 12 citations
Original Research
Published on 08 Jul 2022
Silenced LINC01134 Enhances Oxaliplatin Sensitivity by Facilitating Ferroptosis Through GPX4 in Hepatocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.939605
- 5,479 views
- 30 citations